| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 | 29 Mar 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $237 | |||
| Short term investments | $47 | |||
| Net receivables | $175 | $172 | $224 | |
| Inventory | ||||
| Total current assets | $438 | $458 | $508 | |
| Long term investments | $887 | |||
| Property, plant & equipment | $49 | $46 | $53 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1299 | $1323 | $1395 | |
| Current liabilities | ||||
| Accounts payable | $7 | $6 | $17 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $305 | $321 | $356 | |
| Long term debt | $195 | $194 | $194 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $567 | $581 | $619 | |
| Shareholders' equity | ||||
| Retained earnings | -$2219 | -$2200 | -$2158 | |
| Other shareholder equity | -$13 | -$15 | -$14 | |
| Total shareholder equity | $776 | |||
| (in millions $) | 31 Jan 2025 | 31 Jan 2024 | 28 Mar 2023 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $237 | $426 | $214 | |
| Short term investments | $47 | $182 | $334 | |
| Net receivables | $224 | $135 | $217 | |
| Inventory | ||||
| Total current assets | $508 | $743 | $1006 | |
| Long term investments | $887 | $936 | $30 | |
| Property, plant & equipment | $53 | $69 | $48 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1812 | |||
| Total investments | ||||
| Total assets | $1395 | $1679 | $2818 | |
| Current liabilities | ||||
| Accounts payable | $17 | $24 | $20 | |
| Deferred revenue | $225 | |||
| Short long term debt | $367 | |||
| Total current liabilities | $356 | $729 | $429 | |
| Long term debt | $194 | $720 | ||
| Total noncurrent liabilities | $885 | |||
| Total debt | ||||
| Total liabilities | $619 | $822 | $1314 | |
| Shareholders' equity | ||||
| Retained earnings | -$2158 | -$2028 | -$1306 | |
| Other shareholder equity | -$14 | -$18 | -$13 | |
| Total shareholder equity | $776 | $857 | $1556 | |
| (in millions $) | 30 Oct 2025 | 30 Jul 2025 | 31 Jan 2025 | 30 Oct 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 29 Mar 2024 | 31 Jan 2023 | 28 Mar 2022 | 27 Feb 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $853 | $893 | ||
| Cost of revenue | $250 | |||
| Gross Profit | $520 | $643 | ||
| Operating activities | ||||
| Research & development | $215 | |||
| Selling, general & administrative | $342 | |||
| Total operating expenses | $558 | $989 | ||
| Operating income | -$96 | |||
| Income from continuing operations | ||||
| EBIT | -$96 | |||
| Income tax expense | $24 | -$9 | ||
| Interest expense | $19 | -$15 | ||
| Net income | ||||
| Net income | -$130 | -$1104 | ||
| Income (for common shares) | -$1104 | |||
| (in millions $) | 1 Oct 2024 | 1 Jul 2024 | 29 Mar 2024 | 30 Dec 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $15 | -$26 | $46 | $112 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $1 | $1 | -$165 | -$211 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$12 | -$40 | -$122 | -$87 |
| (in millions $) | 29 Mar 2024 | 28 Mar 2023 | 27 Feb 2022 | 27 Feb 2021 |
|---|---|---|---|---|
| Net income | $12 | -$1104 | ||
| Operating activities | ||||
| Depreciation | $176 | $198 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$28 | $82 | ||
| Investing activities | ||||
| Capital expenditures | -$8 | -$8 | ||
| Investments | $222 | $3 | ||
| Total cash flows from investing | $46 | $176 | $207 | -$65 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$246 | |||
| Total cash flows from financing | -$165 | $6 | $10 | -$227 |
| Effect of exchange rate | -$3 | -$1 | $2 | |
| Change in cash and equivalents | -$122 | -$84 | $188 | -$208 |
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |